Novel oxazolidinone–quinolone hybrid antimicrobials (Q44658896)

5 December 2017

Novel oxazolidinone-quinolone hybrid antimicrobials (English)

1 reference

5 December 2017

Novel oxazolidinone–quinolone hybrid antimicrobials (English)

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

0 references

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

author name string

Corinne Hackbarth

2

1 reference

5 December 2017

Marcela Gomez

7

1 reference

5 December 2017

Joaquim Trias

8

1 reference

5 December 2017

Mikhail F. Gordeev

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Michael R. Barbachyn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Lee S. Banitt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

James R. Gage

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Gary W. Luehr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Sara E. Morin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Gary E. Zurenko

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Christian N. Parker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Jonathan M. Evans

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Richard J. White

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

Dinesh V. Patel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623004

3 April 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0960894X03008813?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

https://api.elsevier.com/content/article/PII:S0960894X03008813?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Bioorganic & Medicinal Chemistry Letters

3 April 2024

published in

1 reference

5 December 2017

13

1 reference

5 December 2017

23

1 reference

5 December 2017

4213-4216

1 reference

Oxazolidinones: new antibacterial agents

5 December 2017

2

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Oxazolidinones: a new class of antibacterials

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

Linezolid

6

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Linezolid: an oxazolidinone antimicrobial agent

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Design, Synthesis and Biological Evaluation of Oxazolidinone–Quinolone Hybrids

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Dual-action cephalosporins: cephalosporin 3'-quinolone carbamates

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Linezolid resistance in a clinical isolate of Staphylococcus aureus

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Linezolid-resistant enterococci: report of the first isolates in the United Kingdom

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

Synthesis and antibacterial activities of optically active ofloxacin and its fluoromethyl derivative

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.07.021

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference